A STING pathway-activatable contrast agent for MRI-guided tumor immunoferroptosis synergistic therapy
Shuai Guo, Wei Xiong, Jiaoyang Zhu, Jie Feng, Ruilong Zhou, Qingdeng Fan, Qianqian Zhang, Zongheng Li, H. J. Yang, Huimin Zhou, Peiwei Yi, Yanqiu Feng, Su‐Geun Yang, Xiaozhong Qiu, Yikai Xu, Zheyu Shen
Topics & Concepts
In vivoCancer researchStingMaterials scienceCancer immunotherapyImmunotherapyCancerMedicineBiologyAerospace engineeringEngineeringBiotechnologyInternal medicineFerroptosis and cancer prognosisinterferon and immune responsesCancer, Hypoxia, and Metabolism